Intriguingly, low levels of CRP after stem cell transplantation therapy for AML and CML are an independent variable predicting the risk of a relapse after stem cell transplantation [58], and conversely high levels of CRP may correlate with recovery [59]. This evidence concerns the gene CRP and chronic myelogenous leukemia, BCR-ABL1 positive.